Follow
Rana Jahanban-Esfahlan
Rana Jahanban-Esfahlan
Assistant Professor of Medical Biotechnology, Tabriz University of Medical Sciences
Verified email at tbzmed.ac.ir
Title
Cited by
Cited by
Year
Tumor microenvironment complexity and therapeutic implications at a glance
R Baghban, L Roshangar, R Jahanban-Esfahlan, K Seidi, ...
Cell Communication and Signaling 18, 1-19, 2020
12142020
The importance of almond (Prunus amygdalus L.) and its by-products
AJ Esfahlan, R Jamei, RJ Esfahlan
Food chemistry 120 (2), 349-360, 2010
2882010
Recent developments in the detection of bovine serum albumin
A Jahanban-Esfahlan, A Ostadrahimi, R Jahanban-Esfahlan, ...
International journal of biological macromolecules 138, 602-617, 2019
2082019
Modulating tumor hypoxia by nanomedicine for effective cancer therapy
R Jahanban‐Esfahlan, M de la Guardia, D Ahmadi, B Yousefi
Journal of cellular physiology 233 (3), 2019-2031, 2018
1882018
Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes
R Jahanban‐Esfahlan, S Mehrzadi, RJ Reiter, K Seidi, M Majidinia, ...
British journal of pharmacology 175 (16), 3230-3238, 2018
1462018
Horizontal gene transfer: from evolutionary flexibility to disease progression
M Emamalipour, K Seidi, S Zununi Vahed, A Jahanban-Esfahlan, ...
Frontiers in cell and developmental biology 8, 229, 2020
1222020
The roles of Wnt/β-catenin pathway in tissue development and regenerative medicine
BY Maryam Majidinia, Javad Aghazadeh, Rana Jahanban-Esfahlani
Journal of Cellular Physiology, 2017
120*2017
A bio-inspired magnetic natural hydrogel containing gelatin and alginate as a drug delivery system for cancer chemotherapy
R Jahanban-Esfahlan, H Derakhshankhah, B Haghshenas, B Massoumi, ...
International journal of biological macromolecules 156, 438-445, 2020
1172020
Latest developments in the detection and separation of bovine serum albumin using molecularly imprinted polymers
A Jahanban-Esfahlan, L Roufegarinejad, R Jahanban-Esfahlan, ...
Talanta 207, 120317, 2020
1172020
Cancer stem cells-emanated therapy resistance: implications for liposomal drug delivery systems
H Dianat-Moghadam, M Heidarifard, R Jahanban-Esfahlan, Y Panahi, ...
Journal of controlled release 288, 62-83, 2018
1172018
Tumor target amplification: implications for nano drug delivery systems
K Seidi, HA Neubauer, R Moriggl, R Jahanban-Esfahlan, T Javaheri
Journal of controlled release 275, 142-161, 2018
1122018
PAMAM dendrimers augment inhibitory effects of curcumin on cancer cell proliferation: possible inhibition of telomerase
M Mollazade, K Nejati-Koshki, A Akbarzadeh, N Zarghami, M Nasiri, ...
Asian Pacific Journal of Cancer Prevention 14 (11), 6925-6928, 2013
1052013
CovidCTNet: an open-source deep learning approach to diagnose covid-19 using small cohort of CT images
T Javaheri, M Homayounfar, Z Amoozgar, R Reiazi, F Homayounieh, ...
NPJ digital medicine 4 (1), 29, 2021
104*2021
An overview on Vadimezan (DMXAA), the vascular disrupting agent
ADF Adli, R Jahanban-Esfahlan, K Seidi, S Samandari-Rad, N Zarghami
96*
The multiple functions of melatonin in regenerative medicine
M Majidinia, RJ Reiter, SK Shakouri, I Mohebbi, M Rastegar, M Kaviani, ...
Ageing research reviews 45, 33-52, 2018
952018
Tumor cell dormancy: threat or opportunity in the fight against cancer
R Jahanban-Esfahlan, K Seidi, MH Manjili, A Jahanban-Esfahlan, ...
Cancers 11 (8), 1207, 2019
942019
Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model
F Tavakoli, R Jahanban-Esfahlan, K Seidi, M Jabbari, R Behzadi, ...
Artificial cells, nanomedicine, and biotechnology 46 (sup2), 75-86, 2018
882018
Tumor vascular infarction: prospects and challenges
R Jahanban-Esfahlan, K Seidi, N Zarghami
International journal of hematology 105, 244-256, 2017
842017
Combination of nanotechnology with vascular targeting agents for effective cancer therapy
R Jahanban‐Esfahlan, K Seidi, B Banimohamad‐Shotorbani, ...
Journal of Cellular Physiology, 2017
842017
Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells
M Nasiri, N Zarghami, KN Koshki, M Mollazadeh, MP Moghaddam, ...
Asian Pac J Cancer Prev 14 (6), 3449-3453, 2013
822013
The system can't perform the operation now. Try again later.
Articles 1–20